Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of CKD-351 for primary open angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• CKD-351

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: UNKNOWN